Efficacy and Safety of Palbociclib Plus Endocrine Therapy (ET) for HR+/HER2-Advanced Breast Cancer (ABC) in the Asian-Pacific (AP) Region

S-A Im, N. Masuda, Y-H Im, K. Inoue, S-B Kim, A. Redfern, J. Lombard, D. Lu, K. P. Theall, E. Gauthier, H. Mukai, J. Ro

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)62-62
Number of pages1
JournalAsia-Pacific Journal of Clinical Oncology
Volume14
Publication statusPublished - Aug 2018

Cite this

Im, S-A., Masuda, N., Im, Y-H., Inoue, K., Kim, S-B., Redfern, A., Lombard, J., Lu, D., Theall, K. P., Gauthier, E., Mukai, H., & Ro, J. (2018). Efficacy and Safety of Palbociclib Plus Endocrine Therapy (ET) for HR+/HER2-Advanced Breast Cancer (ABC) in the Asian-Pacific (AP) Region. Asia-Pacific Journal of Clinical Oncology, 14, 62-62.